Ad
related to: Patents and Vaccines
Search results
New mRNA cancer vaccine triggers fierce immune response to fight malignant brain tumor
Medical Xpress· 6 days agoThe breakthrough now will be tested in a Phase I pediatric clinical trial for brain cancer. Reported...
Do Patent Claims to Methods of Treatment Cover In Vivo Transformations? | JD Supra
JD Supra· 7 days agoWhere an alleged infringer administers a substance A to a subject, and the substance is subsequently transformed to a therapeutic agent X inside the subject’s body, does the administration of ...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 4 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Decoding Moderna Inc (MRNA): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 days agoRegulatory Hurdles: The development and commercialization of new drugs and vaccines are subject to...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
FOX 59 Indianapolis· 6 days agoUSA News Group – An alarming trend is happening around the world, where tens of millions of...
Fighting Tumors with DNA Origami
The Scientist· 1 day agoThe immune system works tirelessly tip nip cancer cells in the bud, but occasionally a tumor wins and takes hold.1 To stop rogue tumor cells in their tracks, researchers are developing cancer ...
Charles Gore
Time Magazine· 5 days agoThe organization Gore leads as executive director, the MedicinesPatent Pool, offers a creative solution to the patent restrictions that can keep drugs...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga· 4 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
GUEST VIEW: Patent proposal will make innovation disappear
Odessa American· 3 days agoLike many of my fellow seniors, I grew up in an era where TVs were boxy and pixelated. News and...
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
Motley Fool via Yahoo Finance· 7 days agos revenue in 2023 fell 42% from the previous year. Sales for the company's top-selling product,...
